C-reactive protein measurement and cardiovascular disease

The Lancet

Volumn 375, Issue 9720, 2010, Pages 1078-

  Habersberger, Jonathon ^a   Eisenhardt, Steffen ^b   Peter, Karlheinz ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HUMAN; LETTER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION;

EID: 77949824713     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60470-9     Document Type: Letter

References (5)

1. The Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 375 (2010) 132-140
2. Elliott P., Chambers J.C., Zhang W., et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302 (2009) 37-48
3. Ji S.R., Wu Y., Zhu L., et al. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J 21 (2007) 284-294
4. Eisenhardt S.U., Habersberger J., Murphy A., et al. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res 105 (2009) 128-137
5. Molins B., Peña E., Vilahur G., Mendieta C., Slevin M., and Badimon L. C-reactive protein isoforms differ in their effects on thrombus growth. Arterioscler Thromb Vasc Biol 28 (2008) 2239-2246